Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil T Darras

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Neuromuscular Disorders : NMD|September 7, 2020
Gain and loss of abilities in type II SMA: A 12-month natural history studyGiorgia Coratti, Simona Lucibello, Maria C Pera, et al.
Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Neurology|June 27, 2025
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient CohortsAmy Pasternak, Michael P McDermott, Jacqueline Montes, et al.
Neurology|February 8, 2024
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ StudyThomas O Crawford, Basil T Darras, John W Day, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|November 18, 2011
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)Allan M Glanzman, Michael P McDermott, Jacqueline Montes, et al.
Neurology|April 26, 2019
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studiesBasil T Darras, Claudia A Chiriboga, Susan T Iannaccone, et al.
JAMA Neurology|March 7, 2022
Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A ReviewSarah U Morton, John Christodoulou, Gregory Costain, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Neuromuscular Disorders : NMD|September 7, 2020
Gain and loss of abilities in type II SMA: A 12-month natural history studyGiorgia Coratti, Simona Lucibello, Maria C Pera, et al.
Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Neurology|June 27, 2025
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient CohortsAmy Pasternak, Michael P McDermott, Jacqueline Montes, et al.
Neurology|February 8, 2024
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ StudyThomas O Crawford, Basil T Darras, John W Day, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|November 18, 2011
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)Allan M Glanzman, Michael P McDermott, Jacqueline Montes, et al.
Neurology|April 26, 2019
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studiesBasil T Darras, Claudia A Chiriboga, Susan T Iannaccone, et al.
JAMA Neurology|March 7, 2022
Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A ReviewSarah U Morton, John Christodoulou, Gregory Costain, et al.
Pageof 23